Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2684565
Title:
UTILISATION DE L'ULIPRISTAL POUR LE TRAITEMENT DES FIBROMES UTERINS
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
131878597
WO application number:
Type:
European patent granted for BE
Status:
Revoked
Publication number:
2684565
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
28/01/2009
Grant date:
02/10/2019
EP publication date:
15/01/2014
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
02/10/2019
EP B1 publication date:
02/10/2019
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/01/2021
Expiration date (if granted and all annual fees paid):
28/01/2029
Revocation Date:
04/02/2022
Applicant
1
Name:
Laboratoire HRA-Pharma
Legal Form:
From:
02/10/2019
Address:
200 avenue de Paris, 92320 Châtillon, France (FR)
To:
2
Name:
The United States of America
as represented by the Secretary,
Department of Health and Human Services
Legal Form:
From:
02/10/2019
Address:
Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard, Suite 325
MSC 7660, Bethesda, MD 20892-7660, United States (US)
To:
Agent
1
Name:
GEVERS PATENTS
Legal Form:
From:
08/02/2024
Address:
De Kleetlaan 7A, 1831, DIEGEM, Belgium (BE)
To:
2
Name:
GEVERS PATENTS
Legal Form:
From:
30/12/2019
Address:
Holidaystraat 5, 1831, DIEGEM, Belgium (BE)
To:
08/02/2024
Inventor
1
Name:
Gainer, Erin
Legal Form:
Address:
75019 Paris, France (FR)
2
Name:
Nieman, Lynnette
Legal Form:
Address:
Bethesda, 20817, United States (US)
3
Name:
Ulmann, André
Legal Form:
Address:
75005 Paris, France (FR)
4
Name:
Blithe, Diana
Legal Form:
Address:
Silver Spring, MD Maryland 20906, United States (US)